|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
108,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
5,721,727 |
Avg
Vol: |
2,617,886 |
52
Week Range: |
$73.89 - $73.89 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Porter Steven Bryant |
Chief Medical Officer |
|
2011-05-12 |
4 |
OE |
$18.12 |
$1,680,726 |
D/D |
82,239 |
146,968 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-05-12 |
4 |
S |
$40.14 |
$5,271,732 |
D/D |
(131,332) |
58,574 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-05-12 |
4 |
OE |
$18.70 |
$2,939,153 |
D/D |
125,260 |
189,906 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-12 |
4 |
S |
$38.84 |
$4,499,118 |
D/D |
(115,842) |
67,576 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-12 |
4 |
OE |
$15.34 |
$2,110,056 |
D/D |
109,770 |
183,418 |
|
- |
|
Seiwert Scott |
SVP, Rsearch & Technical Dev. |
|
2011-05-12 |
4 |
S |
$39.13 |
$2,795,229 |
D/D |
(71,443) |
46,970 |
|
- |
|
Seiwert Scott |
SVP, Rsearch & Technical Dev. |
|
2011-05-12 |
4 |
OE |
$11.93 |
$955,612 |
D/D |
55,148 |
118,413 |
|
- |
|
Leff Jonathan S |
Director |
|
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
21,008 |
21,008 |
|
- |
|
Leff Jonathan S |
Director |
|
2011-05-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,999,993) |
4,485,216 |
|
- |
|
Landy Joseph |
10% Owner |
|
2011-05-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,999,993) |
4,485,216 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
73,648 |
|
- |
|
Di Nepi Giacomo |
SVP, Managing Director, Europe |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
27,000 |
|
- |
|
Seiwert Scott |
SVP, Rsearch & Technical Dev. |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
63,265 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
287,555 |
|
- |
|
Steele Robin Joan |
SVP, GC, Secretary |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
85,610 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
64,729 |
|
- |
|
Hodgman John |
SVP-Finance & CFO |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
68,268 |
|
- |
|
Cohen Alan Howard |
SVP, Medical Affairs |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
27,000 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
64,646 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-04 |
4 |
AS |
$44.09 |
$264,565 |
D/D |
(6,000) |
66,648 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-05-04 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
72,648 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-05-04 |
4 |
AS |
$44.03 |
$248,816 |
D/D |
(5,651) |
57,646 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-05-04 |
4 |
OE |
$15.34 |
$86,686 |
D/D |
5,651 |
63,297 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-05-04 |
4 |
AS |
$44.03 |
$242,164 |
D/D |
(5,500) |
57,729 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-05-04 |
4 |
OE |
$15.34 |
$84,370 |
D/D |
5,500 |
63,229 |
|
- |
|
772 Records found
|
|
Page 12 of 31 |
|
|